Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses

NCT01922284 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: DNA
BIOLOGICAL: MVA-C
BIOLOGICAL: CN54rgp140
BIOLOGICAL: GLA-AF

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]